Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

A new compound effectively inhibits human 5α-reductase 1.

Nilotinib can cause skin issues like red bumps and hair loss.

Pegvaliase is recommended for treating adults with phenylketonuria.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Compound 1 showed promising anticancer activity.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Bicalutamide improves hair density in women safely.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Compound 7p shows strong potential as an anticancer agent.

Phyllanthus emblica leaves show potential for developing new antimalarial drugs with low toxicity.

CTP-543 is generally safe for treating alopecia areata.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Researchers made new compounds that could potentially be developed into anticancer drugs.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.